Friday, July 15, 2011

New Data on Effect of "Black Box" Warning for Children Using Antidepressants

Jorge Salcedo/Shutterstock
How did the 2003 FDA advisory warning on suicidality among children using SSRI antidepressants affect the recognition and treatment of depression in children? A new analysis appearing in Psychiatric Services (July 2011) indicates that the so-called “black box” warning may have diminished the likelihood of making an outpatient visit for depression but not the prescription of an antidepressant in the case of a diagnosis of depression. “National Trends in Prescribing an Antidepressant Before and After an FDA Advisory on Suicidality Risk in Youths” is posted at For further coverage of the findings, see the next issue of Psychiatric News, and for information on the “black box” warning, see


The content of Psychiatric News does not necessarily reflect the views of APA or the editors. Unless so stated, neither Psychiatric News nor APA guarantees, warrants, or endorses information or advertising in this newspaper. Clinical opinions are not peer reviewed and thus should be independently verified.